Nainu, F.; Bahar, M.A.; Sartini, S.; Rosa, R.A.; Rahmah, N.; Kamri, R.A.; Rumata, N.R.; Yulianty, R.; Wahyudin, E.
Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators. Sci. Pharm. 2022, 90, 11.
https://doi.org/10.3390/scipharm90010011
AMA Style
Nainu F, Bahar MA, Sartini S, Rosa RA, Rahmah N, Kamri RA, Rumata NR, Yulianty R, Wahyudin E.
Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators. Scientia Pharmaceutica. 2022; 90(1):11.
https://doi.org/10.3390/scipharm90010011
Chicago/Turabian Style
Nainu, Firzan, Muh. Akbar Bahar, Sartini Sartini, Reski Amalia Rosa, Nur Rahmah, Reski Amelia Kamri, Nur Rahma Rumata, Risfah Yulianty, and Elly Wahyudin.
2022. "Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators" Scientia Pharmaceutica 90, no. 1: 11.
https://doi.org/10.3390/scipharm90010011
APA Style
Nainu, F., Bahar, M. A., Sartini, S., Rosa, R. A., Rahmah, N., Kamri, R. A., Rumata, N. R., Yulianty, R., & Wahyudin, E.
(2022). Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators. Scientia Pharmaceutica, 90(1), 11.
https://doi.org/10.3390/scipharm90010011
